1. © The Author(s) 2015. Published by Science and Education Publishing.
Table 3. Medication related variables among T2DM patients at WSU teaching hospital
Medication related variables
Frequency (%)
Antihypertensive Drugs
No of medications taken per day (mean± SD)
3.33±1.38
ACEIs
127 (57.5)
Below (<5)
195 (80.25)
Calcium channel blockers
61 (27.6)
Above(>5) (polypharmacy)
48 (19.75)
Diuretics
23(10.4)
Beta blockers
10(4.5)
Other Concurrently used medications
(N=66)
Frequency/number of doses per day (mean±SD)
2.34 ± 0.47
Acid lowering drugs
32 (48.5)
<Twice
160 (65.8)
Antibiotics
14 (21.2)
Three times and above
83 (34.2)
NSAIDs
11 (16.7)
Others*
9 (13.6)
Statins
Anti-diabetic medications
Yes
60 (24.7)
Metformin
13 (5.3) No
183(75.3)
Glibenclamide
62 (25.5)
Antiplatelet
Insulin
44(18.1)
Metformin and Glibenclamide
116 (47.7)
199(81.9)
Metformin and insulin
26 (10.7)
MMAS**
Insulin and Glibenclamide
12 (4.9)
< 3
116(47.7)
Metformin + Glibenclamide + insulin
1 (0.4)
> 3
127(52.3
* ARV drugs, anti-asthmatics, anti-epileptics, steroids ** Morisky medication adherence score.
Hailu Chare Koyra et al. Epidemiology and Predictors of Drug Therapy Problems among Type 2 Diabetic Patients at
Wolaita Soddo University Teaching Hospital, Southern Ethiopia. American Journal of Pharmacological Sciences, 2017,
Vol. 5, No. 2, doi: /ajps-5-2-4
© The Author(s) Published by Science and Education Publishing.